Results 181 to 190 of about 10,942 (204)
Some of the next articles are maybe not open access.
Towards selective lysophospholipid GPCR modulators
Trends in Pharmacological Sciences, 2014G-protein-coupled receptors (GPCRs) that recognize the lysophospholipids (LPLs) are grouped into two phylogenetically distinct families: the endothelial differentiation gene (Edg) and non-Edg GPCRs. Owing to their more recent identification, and hindered by a lack of selective pharmacological tools, our understanding of the functions and signaling ...
Archbold, Julia K. +2 more
openaire +3 more sources
Lysophospholipid receptors in cell signaling
Biochemistry (Moscow), 2007There is increasing evidence that different phospholipids are involved in regulation of various cell processes and cell-cell interactions. Lysophospholipids (lysophosphatidic acid, lysophosphatidylcholine) and a number of lysosphingolipids play particular roles in these regulations. Their effects are mediated by specific G-protein-coupled receptors.
T I, Torkhovskaya +4 more
openaire +2 more sources
Lysophospholipids and the cardiovascular system
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2002The lysophospholipids sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) have varied effects on the cardiovascular system. S1P is necessary for normal vascular development and may play an important role in angiogenesis. These molecules may exert potentially detrimental effects.
openaire +2 more sources
Stem cell regulation by lysophospholipids
Prostaglandins & Other Lipid Mediators, 2007Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) regulate a diverse range of mammalian cell processes, largely through engaging multiple G protein-coupled receptors specific for these lysophospholipids. LPA and S1P have been clearly identified to have widespread physiological and pathophysiological actions, controlling events within the ...
Pebay, A., Bonder, C., Pitson, S.
openaire +3 more sources
Mechanisms of cardioprotection by lysophospholipids
Journal of Cellular Biochemistry, 2004AbstractThe lysophospholipids sphingosine 1‐phosphate (S1P) and lysophosphosphatidic acid (LPA) reduce mortality in hypoxic cardiac myocytes. S1P is also cardioprotective in both mouse and rat models of cardiac ischemia/reperfusion (I/R) injury. Although these results are consistent with prior work in other cell types, it is not known what signaling ...
openaire +2 more sources
Lysophospholipid Acylation in RBC.
Blood, 2006AbstractThe formation, distribution and utilization of acyl-CoA plays a crucial role in plasma membrane phospholipid turnover in red blood cells (RBC). Upon de-acylation of glycero-phospholipids (PL) via the action of phospholipase, re-acylation of the lysophospholipids (LPL) requires activity of two enzymes of the Lands pathway.
Eric Soupene, Frans A. Kuypers
openaire +1 more source
Lysophospholipids in the nervous system
Prostaglandins & Other Lipid Mediators, 2005This piece offers perspectives on the emerging roles of lysophospholipids, which include lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), for the biology and pathophysiology of the nervous system. It reflects opinions generated during a meeting sponsored by the National Institute on Drug Abuse (NIDA) entitled "Targeted Lipidomics ...
openaire +2 more sources
Lysophospholipids as Mediators of Immunity
2006Lysophospholipids (LPLs) are lipid-derived signaling molecules exemplified by lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P). Originally identified as serum-associated growth factors, these mediators now are known to signal through a family of diverse G protein-coupled receptors (GPCRs). Virtually all cells that participate in the immune
Debby A, Lin, Joshua A, Boyce
openaire +2 more sources
Lysophospholipid‐Induced Cell Migration
Annals of the New York Academy of Sciences, 2000T S, Panetti, D F, Mosher
openaire +2 more sources